Acute hepatitis secondary to interferon beta-1a in multiple sclerosis

被引：6

作者：

Christopher, V ^{[1
]}

Scolding, N ^{[1
]}

Przemioslo, R ^{[1
]}

机构：

[1] Frenchay Hosp, Dept Gastroenterol, Bristol BS16 1LE, Avon, England

来源：

JOURNAL OF NEUROLOGY | 2005年 / 252卷 / 07期

关键词：

D O I：

10.1007/s00415-005-0767-2

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：855 / 856

页数：2

共 7 条

[1]

Duchini A, 2002, AM J GASTROENTEROL, V97, P767

[2]

Francis G, 2001, NEUROLOGY, V56, P1628

[3] Hepatic reactions during treatment of multiple sclerosis with interferon-β-1a -: Incidence and clinical significance [J].

Francis, GS ;

Grumser, Y ;

Alteri, E ;

Micaleff, A ;

O'Brien, F ;

Alsop, J ;

Moraga, MS ;

Kaplowitz, N .

DRUG SAFETY, 2003, 26 (11) :815-827

[4] Interferon β-1a in primary progressive MS -: An exploratory, randomized, controlled trial [J].

Leary, SM ;

Miller, DH ;

Stevenson, VL ;

Brex, PA ;

Chard, DT ;

Thompson, AJ .

NEUROLOGY, 2003, 60 (01) :44-51

[5]

RAMKUMAR D, 2003, DRUG INDUCED LIVER D, pCH27

[6] Multiple sclerosis - Side effects of interferon beta therapy and their management [J].

Walther, EU ;

Hohlfeld, R .

NEUROLOGY, 1999, 53 (08) :1622-1627

[7] Fulminant liver failure during interferon beta treatment of multiple sclerosis [J].

Yoshida, EM ;

Rasmussen, SL ;

Steinbrecher, UP ;

Erb, SR ;

Scudamore, CH ;

Chung, SW ;

Oger, JJ ;

Hashimoto, SA .

NEUROLOGY, 2001, 56 (10) :1416-1416

← 1 →